Rondo Therapeutics Announces Collaboration With Lilly to Develop Novel Cd28 Bispecific Antibodies for Solid Tumors
Rondo Therapeutics宣布与Lilly合作开发用于实体肿瘤的新型Cd28双特异性抗体
Rondo Therapeutics Announces Collaboration With Lilly to Develop Novel Cd28 Bispecific Antibodies for Solid Tumors
Rondo Therapeutics宣布与Lilly合作开发用于实体肿瘤的新型Cd28双特异性抗体
使用浏览器的分享功能,分享给你的好友吧